Advanced Techniques in pMDI Characterisation: Insights from Ab Initio and OzUK

Click on Image to access our Knowledge Hub Article

Ab Initio Pharma and OzUK have published a groundbreaking article that delves into advanced techniques for the characterisation of pressurised metered dose inhalers (pMDIs). This research highlights innovative methods for assessing the dissolution and performance of pMDIs, particularly in the context of transitioning to more environmentally friendly propellants. The article showcases the companies' expertise in developing robust tools and methodologies that ensure consistent drug delivery and efficacy during formulation changes, making a significant contribution to the field of pulmonary drug delivery. Read the article at our Knowledge Hub or by clicking the image

Previous
Previous

Ab Initio Pharma Announces Sponsorship of the 2024 NSW Drug Discovery Forum Commercialisation Award

Next
Next

Ab Initio Pharma Team Shines at Sydney City to Surf Event